Placeholder Banner

BIO Files Amicus Brief Supporting Rehearing of Case Addressing Patent Rights and America Invents Act (AIA) at the U.S. Court of Appeals for the Federal Circuit

July 14, 2017

BIO filed an amicus brief in support of a petition to rehear Helsinn Healthcare S.A. v. TEVA Pharmaceuticals USA, Inc., TEVA Pharmaceutical Industries Ltd. at the U.S. Court of Appeals for the Federal Circuit.

Because modern biotechnological products commonly involve lengthy, resource- and investment-intensive development periods, BIO members depend heavily on robust patent rights and a fair system for adjudicating their validity. Accordingly, it’s important to have certainty regarding the types of transactions and what must be publicly disclosed about those transactions to qualify as invalidating activities under the on-sale bar of the America Invents Act (AIA).

Related Resources
2016-1284, -1787 The Biotechnology Innovation Organization (BIO) As Amicus Curiae Supporting Rehearing En Banc
BIO Brief supporting rehearing en banc in Helsinn v. Teva Phamaceuticals
Discover More
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners.